EMSN.SW Ems-Chemie (SIX) intraday CHF596.00 on 03 Feb 2026: earnings due Feb 6 — what to watch
EMSN.SW stock trades intraday at CHF596.00, down -0.83% (-5.00) from yesterday. Volume is light at 2,846.00 shares versus a 50-day average of 13,248.00. Investors are focused on the upcoming earnings release on 06 Feb 2026 at 16:30 UTC. Key near-term metrics include EPS 19.89 and PE 30.04, with market cap at CHF13,974,944,230.00. This earnings spotlight previews margins, cash flow, and guidance ahead of the report.
Earnings outlook: EMSN.SW stock
Earnings due on 06 Feb 2026 are the main catalyst for intraday moves. Management may comment on demand in automotive and electronics. Consensus numbers are thin, so surprises could swing price by several percent. We watch operating profit margin and guidance for H1 2026.
What the numbers say: EMSN.SW financials
Ems-Chemie reports solid cash generation with operating cash flow per share 20.71. Net income per share is 19.75 and book value per share is 89.83. Return on equity is 23.64%, and debt is negligible with debt to equity 0.01. These figures support a premium valuation versus many peers.
Valuation and price targets: EMSN.SW analysis
Current PE stands at 30.04 against the Swiss Basic Materials sector average PE 17.67. That premium reflects higher margins and strong ROIC 20.65%. Reasonable near-term price targets are conservative CHF540.00, base CHF600.00, and bullish CHF660.00. Targets reflect multiples and cash yields.
Technical picture and trading: EMSN.SW trading
The intraday range is CHF595.00–CHF599.00 with RSI 67.54, close to overbought territory. Short-term moving averages support the price at CHF564.79 (50-day). Average volume is below the five-day norm, suggesting limited conviction ahead of earnings.
Risks and opportunities: EMSN.SW investment
Risks include a demand slowdown in automotive and margin pressure from raw materials. Opportunities include product mix gains and improved pricing power. Dividend yield is meaningful at 2.89% and free cash flow yield sits near 3.23%, providing income support.
Meyka grade and forecast: EMSN.SW report and model
Meyka AI rates EMSN.SW with a score out of 100. Meyka AI rates EMSN.SW with a score 70.00, Grade B+, suggestion BUY. This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly CHF612.07 and yearly CHF516.76. Forecasts are model-based projections and not guarantees. For more company detail visit Ems Group and our stock page Meyka EMSN.SW page.
Final Thoughts
EMSN.SW stock is trading at CHF596.00 ahead of earnings on 06 Feb 2026. The company shows strong cash flow and a robust ROE of 23.64%. Short-term catalysts are earnings detail and management guidance. Meyka AI’s forecast model projects monthly CHF612.07, implying +2.70% upside from today, and yearly CHF516.76, implying -13.30% downside. Use the earnings release to weigh guidance changes against a premium PE of 30.04. Our suggested short-term price bands remain CHF540.00–CHF660.00, tied to margin and order trends. Forecasts are model-based projections and not guarantees. Meyka AI is an AI-powered market analysis platform offering data-driven context for investors.
FAQs
When does EMSN.SW stock report earnings and why does it matter?
Ems-Chemie reports on 06 Feb 2026 at 16:30 UTC. The update matters because guidance and margin detail will affect forecasts and could move EMSN.SW stock by several percent.
What valuation metrics should investors watch for EMSN.SW stock?
Monitor PE 30.04, EPS 19.89, and free cash flow yield 3.23%. Compare these to peers in Chemicals – Specialty to assess premium valuation for EMSN.SW stock.
How does Meyka AI view EMSN.SW stock ahead of earnings?
Meyka AI gives EMSN.SW a B+ (70.00) score with a BUY suggestion based on growth, margins, and cash flow. This is informational and not financial advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)